Hybridomas are laboratory-created cells made by fusing two type of cells, usually an antibody-producing B-cell and a cancer cell. They are used in research or therapeutics to produce a specific single type of antibody known as a monoclonal antibody. Monoclonal antibodies are becoming increasingly important in the development of targeted therapies for a wide range of illnesses. They are also used to detect and quantify proteins, and in diagnostic tests. Examples of hybridomas include the production of the humanized monoclonal antibody trastuzumab (Herceptin), used in the treatment of breast cancer. Hybridomas are a valuable tool in the fight against various diseases, and offer a means to improve the accuracy and efficiency of diagnostic tests.

From: International Journal of Cell

Related Article For "Hybridomas"

About (1) results

Editor: Zhong Ye, Clinical Research Specialist, Thomas Jefferson University
Publication Type: Open Access Journal
Description: International Journal of Cell is a multidisciplinary journal that covers wide scope in the area of life sciences. It provides a platform to research investigators, scholars, medical practitioners for sharing their contributions on the recent advances and techniques related to cell and its development.